With the recent CLIA lab certification (the US lab in San Diego), Biovica is moving into the next stage. The US sales team has already identified and established meetings with a large part of the NCI Designated Cancer Center network. The NCI target is, in our view, a sensible approach as these centres tend to be research oriented with the ambition to be leaders in laboratory and clinical research and well-funded. This network involves some 63 centres that meet patients (out of 71), and the NCI network covers most of the US, most located on the East and the West coast.